secwatch.observer — SEC 8-K summary
======================================

Issuer:     Editas Medicine, Inc. (EDIT)
CIK:        0001650664
Form:       8-K
Filed at:   2024-05-31T23:59:59+00:00
Accession:  0001650664-24-000050
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Editas Medicine stockholders elect Class II directors, approve say-on-pay, ratify auditor
--------------------------------------------------------------------------------

- Elected Meeta Chatterjee, Andrew Hirsch, Gilmore O'Neill as Class II directors for term until 2027 annual meeting.
- Advisory say-on-pay approved with 38,609,828 votes for, 2,769,887 against, 205,788 abstentions.
- Ratified Ernst & Young as independent auditor for fiscal 2024 with 57,952,408 votes for, 362,117 against, 1,036,297 abstentions.
- Broker non-votes of 17,765,319 on director election and say-on-pay; none on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1650664/000165066424000050/0001650664-24-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1650664/000165066424000050/edit-20240530.htm
  HTML page:      https://secwatch.observer/filing/0001650664-24-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer